Aberdeen Group’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,810
Closed -$2.4M 1072
2021
Q4
$2.4M Buy
26,810
+1,523
+6% +$129K 0.01% 752
2021
Q3
$1.96M Buy
25,287
+374
+2% +$28.1K ﹤0.01% 790
2021
Q2
$1.78M Buy
24,913
+13,177
+112% +$960K ﹤0.01% 792
2021
Q1
$795K Buy
11,736
+4,067
+53% +$282K ﹤0.01% 883
2020
Q4
$561K Buy
7,669
+2,286
+42% +$166K ﹤0.01% 871
2020
Q3
$377K Buy
5,383
+1,733
+47% +$136K ﹤0.01% 874
2020
Q2
$266K Buy
+3,650
New +$260K ﹤0.01% 903
2018
Q4
Sell
-146,993
Closed -$9.32M 921
2018
Q3
$9.32M Sell
146,993
-135,176
-48% -$8.75M 0.02% 504
2018
Q2
$16.5M Buy
+282,169
New +$15.3M 0.03% 407

Other funds holding CONE

Aberdeen Group's CONE Position: Q1 2022 in Review

Aberdeen Group sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 26,810 shares — an estimated $2.4M sold.

Aberdeen Group first reported a position in CONE in Q2 2018 and held it in 9 quarters. The position peaked at $16.5M in Q2 2018. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Aberdeen Group reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Aberdeen Group sold 26,810 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $2.4M.
  • Aberdeen Group first reported a position in CyrusOne Inc Common Stock in Q2 2018 and held it in 9 quarters.
  • Aberdeen Group's CyrusOne Inc Common Stock position peaked at $16.5M in Q2 2018.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Aberdeen Group's 13F filing for Q1 2022, filed 4 May 2022.